Zydus Wellness Key Ratios
NSE: ZYDUSWELL | BSE: 531335
₹530.40
As on 31-Aug-2026IST
Market cap
₹16,877 Cr
Revenue (TTM)
₹4,537 Cr
P/E Ratio
89.7
P/B Ratio
2.8
Div. Yield
0.2 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -3.21 | 66.92 | 66.27 | 26.14 | 18.68 |
| EBIT | -14.06 | 27.49 | 15.99 | 12.67 | 3.48 |
| Net Profit | -26.60 | -7.04 | -28.48 | -9.33 | -4.67 |
| EPS | -26.60 | -7.04 | -42.46 | -12.80 | 3.27 |
| Book Value | -- | -- | 2.72 | 4.38 | 5.00 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Mar-26 | Mar-25 |
| EBIT-Margin
| 9.99 | 12.77 | 8.84 | 8.98 | 12.94 |
| Net Margin
| 9.06 | 11.62 | 4.14 | 4.96 | 12.74 |
| Return on equity
| 0.83 | 5.52 | 3.99 | 3.43 | 6.29 |
| Return on Capital
| 1.22 | 5.63 | -- | 4.42 | 6.43 |
| Return on Assets
| 0.81 | 4.72 | 2.25 | 2.39 | 5.65 |
| Debt to Equity (x)
| -- | -- | 0.52 | 0.55 | 0.03 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
ROE
3.99
Lower than Peers by 17.24
Profit after tax / Average Net worth * 100
ROA
2.25
Lower than Peers by 12.30
Profit after tax / Average Total assets * 100
EBIT Margin
8.84
Lower than Peers by 9.00
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Zydus Wellness
|
8.84
|
8.98
|
12.94
|
12.21
|
13.85
|
15.87
|
|||||
|
Peer Median
|
17.84
|
18.52
|
19.37
|
16.48
|
18.38
|
18.00
|
Net Margin
4.14
Lower than Peers by 10.76
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Zydus Wellness
|
4.14
|
4.96
|
12.74
|
11.40
|
13.74
|
15.28
|
|||||
|
Peer Median
|
14.90
|
13.55
|
15.11
|
13.91
|
15.46
|
14.75
|
Cash Profit Margin
--
--
(Net profit + Depreciation) / Gross Sales * 100
Revenue Growth
66.27
Higher than Peers by 61.62
Year on year growth in net sales
EBIT Growth
15.99
Higher than Peers by 12.09
Year on year growth in operating profit (EBIT)
Net Profit Growth
-28.48
Lower than Peers by 32.30
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Zydus Wellness
|
-28.48
|
-43.15
|
29.97
|
-14.01
|
0.50
|
160.14
|
|||||
|
Peer Median
|
3.82
|
-3.34
|
1.53
|
-2.19
|
3.62
|
17.13
|
EPS Growth
-42.46
Lower than Peers by 45.37
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Zydus Wellness
|
-42.46
|
-43.15
|
29.97
|
-14.01
|
0.54
|
160.15
|
|||||
|
Peer Median
|
2.91
|
8.09
|
6.67
|
--
|
3.62
|
17.13
|
Book Value Growth
--
--
Year on year growth in book value per share
Solvency
Debt to Equity
0.52
--
Total debt / Net worth
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
Current Ratio
1.88
Higher than Peers by 0.18
Current Assets / Current Liabilities and Provisions
Quick Ratio
0.83
Lower than Peers by 0.51
(Current Assets - Inventory) / Current Liabilities and Provisions
Interest Coverage
3.03
Lower than Peers by 35.64
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Zydus Wellness
|
3.03
|
3.35
|
30.90
|
11.84
|
19.07
|
13.00
|
|||||
|
Peer Median
|
38.67
|
43.96
|
42.69
|
32.13
|
44.18
|
44.18
|
Operating Efficiency
Debtors to sales
8.46
Higher than Peers by 1.01
Debtors outstanding / Net Sales * 100
Asset Turnover
0.54
Lower than Peers by 0.38
Sales / Average Total Assets
Receivable days
--
--
Average Debtors / Sales * 365
Inventory Days
--
--
Average Inventory / Sales * 365
Payable days
--
--
Average Creditors / Cost of goods sold * 365
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
Valuation
Price / Earnings
89.68
Higher than Peers by 56.44
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Zydus Wellness
|
89.68
|
68.71
|
6.13
|
35.05
|
31.76
|
30.92
|
|||||
|
Peer Median
|
33.24
|
33.24
|
51.77
|
52.73
|
43.57
|
58.46
|
Price / Book Value
2.84
Lower than Peers by 4.28
Current share price divided by book value per share in the latest financial year
Dividend Yield
0.23
Lower than Peers by 1.81
Dividend per share in the past twelve months divided by current share price
EV/EBITDA
33.09
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Zydus Wellness
|
33.09
|
32.21
|
27.31
|
29.31
|
29.56
|
27.48
|
|||||
|
Peer Median
|
--
|
32.38
|
43.63
|
40.96
|
35.09
|
42.90
|
Market Cap
16,877
Lower than Peers by 9,403
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Mar-26
|
Mar-25
|
Mar-24
|
Mar-23
|
Mar-22
|
Mar-21
|
Mar-20
|
Mar-19
|
Mar-18
|
Mar-17
|
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Zydus Wellness
|
16,877
|
13,550
|
10,631
|
9,355
|
9,857
|
9,549
|
|||||
|
Peer Median
|
26,280
|
26,280
|
52,262
|
46,433
|
43,509
|
24,922
|